Table 3.
Subject Characteristics
| Subject | Baseline WAB AQ | Gender | Age | Time post-stroke (months) | Lesion Location | Lesion Size (% left hemisphere cortical volume) |
|---|---|---|---|---|---|---|
| Mild-moderate | ||||||
| 002 (CS/LT) | 82.25 | M | 51 | 194.7 | Fronto-insular | 5 |
| 016 (LT) | 79.95 | M | 42 | 12.4 | Temporal | 8 |
| Moderate | ||||||
| 015 (CS/LT) | 72.00 | M | 57 | 13.3 | Fronto-parietal | 11 |
| 005 (LT) | 59.45 | F | 56 | 12.7 | Fronto-temporal | 17 |
| Moderate-severe | ||||||
| 014 (CS/LT) | 45.85 | M | 34 | 13.7 | Temporal | 10 |
| 001 (LT) | 40.0 | M | 61 | 29.8 | Fronto-insular | 7 |
| Severe | ||||||
| 008 (CS/LT) | 34.20 | F | 60 | 40.8 | Parietal | 13 |
| 012 (LT) | 30.75 | M | 47 | 13.1 | Parieto-temporal | 15 |
For all participants except 001, baseline WAB AQ scores represent the average score of two administrations because more than 30 days had lapsed between baseline assessment and treatment initiation. Subjects are paired for severity based on the initial WAB AQ score, not the averaged baseline score.